Last reviewed · How we verify
NCT06320366
Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder
NA trial testing Sham TMS in Methamphetamine Use Disorder in 20 participants. Currently enrolling.
31 May 2028
Quick facts
| Lead sponsor | University of Colorado, Denver |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 3 September 2024 |
| Primary completion | 31 May 2028 |
| Estimated completion | 31 May 2028 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Sham TMS
- Active TMS
Conditions studied
- Methamphetamine Use Disorder — all drugs for Methamphetamine Use Disorder →
Sponsor
University of Colorado, Denver
Who can join
Adults 21 to 65, any sex, with Methamphetamine Use Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators will evaluate the effects of an accelerated Transcranial Magnetic Stimulation (TMS) protocol of the left dorsolateral prefrontal cortex (DLPFC) for moderate to severe methamphetamine use disorder. This is a randomized parallel group design to assess feasibility and safety, evaluate efficacy (use, craving) and identify magnetic resonance imaging (resting state and cue craving) associated with group/outcomes.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Recruitment feasibility for deep brain stimulation compared to transcranial magnetic stimulation treatment trials for methamphetamine use disorder.
Sakai J, Tanabe J, Raymond K, Gerecht PD, et al · · 2026 · PMID 42220457 · DOI 10.1016/j.abrep.2026.100711
Verify or expand the search:
- PubMed search for NCT06320366
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Sham TMS
Trials testing the same drug.
- NCT07415772 — Effect of cTBS on Startle and TMS-evoked BOLD · NA · not yet recruiting
- NCT06830980 — Transcranial Magnetic Stimulation for Methamphetamine Use Disorder in PLWH · NA · recruiting
- NCT06407141 — The Effect of TPS on Cognitive Functions in Older Adults With MCI · NA · enrolling by invitation
- NCT06077370 — dTMS in Obsessive Compulsive Disorder · NA · completed
- NCT05295953 — Accelerated Transcranial Magnetic Stimulation (TMS) for Smoking Cessation in People Living With HIV/AIDS (PLWHA) · NA · completed
Other recruiting trials for Methamphetamine Use Disorder
Currently open trials in the same condition.
- NCT07226596 — Non-Abstinence Outcomes in Methamphetamine Use Disorder · NA · recruiting
- NCT07450027 — LRFN5 and OLFM4 in Methamphetamine-Induced Psychosis · recruiting
- NCT06989853 — Methamphetamine and Troriluzole · EARLY_PHASE1 · recruiting
- NCT07459244 — ECG Findings in Methamphetamine Use · recruiting
- NCT06712446 — A Pilot Study of Transcranial Magnetic Stimulation Plus Episodic Future Thinking for Methamphetamine Use Disorder · NA · recruiting
Other University of Colorado, Denver trials
Trials by the same sponsor.
- NCT07292285 — The Surveillance Nonoperative Watch & Wait (SNOWW) Rectal Cancer Trial. · not yet recruiting
- NCT07021937 — Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity · Phase 3 · not yet recruiting
- NCT07453732 — Banana Leaves as a Wound Dressing for Partial Thickness Second Degree Burns in Adult Patients. · NA · not yet recruiting
- NCT07038278 — 5-AminoLevulinic Acid Aided Resection Margins in Sarcoma · EARLY_PHASE1 · not yet recruiting
- NCT07279558 — Cannabidiol and Alcohol Use Disorder Phenotypes · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06320366 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Colorado, Denver
- Last refreshed: 3 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06320366.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing